[
  {
    "query": "What is the relationship between cardiovascular risk factors and Alzheimer's disease genetics?",
    "answer": "[30413934_sent_1] Cardiovascular (CV)- and lifestyle-associated risk factors (RFs) are increasingly recognized as important for Alzheimer's disease pathogenesis. [31055733_sent_1] Alzheimer's disease (AD) is highly heritable and recent studies have identified over 20 disease-associated genomic loci. [30413934_sent_10] We pinpoint a subset of cardiovascular-associated genes that strongly increase the risk for AD.",
    "citations": {
      "30413934_sent_1": {
        "text": "Cardiovascular (CV)- and lifestyle-associated risk factors (RFs) are increasingly recognized as important for Alzheimer's disease (AD) pathogenesis.",
        "source": "Abstract_30413934"
      },
      "31055733_sent_1": {
        "text": "Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the interplay of multiple genetic and non-genetic factors.",
        "source": "Abstract_31055733"
      },
      "30617256_sent_1": {
        "text": "Alzheimer's disease (AD) is highly heritable and recent studies have identified over 20 disease-associated genomic loci.",
        "source": "Abstract_30617256"
      },
      "30413934_sent_10": {
        "text": "We pinpoint a subset of cardiovascular-associated genes that strongly increase the risk for AD.",
        "source": "Abstract_30413934"
      }
    },
    "num_sources": 4
  },
  {
    "query": "Which novel genes were identified as associated with both AD and lipid metabolism?",
    "answer": "[30413934_sent_10]",
    "citations": {
      "30413934_sent_9": {
        "text": "Beyond APOE, we show that the polygenic component of AD is enriched for lipid-associated RFs.",
        "source": "Abstract_30413934"
      },
      "30413934_sent_4": {
        "text": "In fold enrichment plots, we observed robust genetic enrichment in AD as a function of plasma lipids (TG, TC, LDL, and HDL); we found minimal AD genetic enrichment conditional on BMI, T2D, CAD, and WHR.",
        "source": "Abstract_30413934"
      },
      "30617256_sent_9": {
        "text": "These results are a step forward in identifying the genetic factors that contribute to AD risk and add novel insights into the neurobiology of AD.",
        "source": "Abstract_30617256"
      },
      "30413934_sent_10": {
        "text": "We pinpoint a subset of cardiovascular-associated genes that strongly increase the risk for AD.",
        "source": "Abstract_30413934"
      }
    },
    "num_sources": 4
  },
  {
    "query": "What are the main findings from the IGAP consortium regarding AD-associated SNPs?",
    "answer": "The identified and/or confirmed 19 single-nucleotide polymorphisms (SNPs) associated with AD are located on non-coding DNA regions, and their functional impacts on AD are as yet poorly understood.",
    "citations": {
      "30448613_sent_4": {
        "text": "For (1), we confirmed that 12 AD-associated coding common SNPs and five nonsynonymous rare variants are in linkage disequilibrium with the IGAP SNPs.",
        "source": "Abstract_30448613"
      },
      "30448613_sent_7": {
        "text": "The IGAP SNPs in ABCA7, CD2AP, and CD33 each acted as eQTL for AD-associated genes in brain.",
        "source": "Abstract_30448613"
      },
      "30448613_sent_1": {
        "text": "The International Genomics of Alzheimer's Project (IGAP) is a consortium for characterizing the genetic landscape of Alzheimer's disease (AD).",
        "source": "Abstract_30448613"
      },
      "30448613_sent_2": {
        "text": "The identified and/or confirmed 19 single-nucleotide polymorphisms (SNPs) associated with AD are located on non-coding DNA regions, and their functional impacts on AD are as yet poorly understood.",
        "source": "Abstract_30448613"
      }
    },
    "num_sources": 4
  },
  {
    "query": "How do MBLAC1, MINK1, and DDB2 genes relate to Alzheimer's disease?",
    "answer": "[30413934_sent_8] Expression of MBLAC1, SPI1, MINK1 and DDB2 was differentially altered within postmortem AD brains. [31055733_sent_1] Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the interplay of multiple genetic and non-genetic factors. [30617256_sent_1] Alzheimer's disease (AD) is highly heritable and recent studies have identified over 20 disease-associated genomic loci. [30448613_sent_1] The International Genomics of Alzheimer's Project (IGAP) is a consortium for characterizing the genetic landscape of Alzheimer's disease (AD).",
    "citations": {
      "30413934_sent_8": {
        "text": "Expression of MBLAC1, SPI1, MINK1 and DDB2 was differentially altered within postmortem AD brains.",
        "source": "Abstract_30413934"
      },
      "31055733_sent_1": {
        "text": "Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the interplay of multiple genetic and non-genetic factors.",
        "source": "Abstract_31055733"
      },
      "30617256_sent_1": {
        "text": "Alzheimer's disease (AD) is highly heritable and recent studies have identified over 20 disease-associated genomic loci.",
        "source": "Abstract_30617256"
      },
      "30448613_sent_1": {
        "text": "The International Genomics of Alzheimer's Project (IGAP) is a consortium for characterizing the genetic landscape of Alzheimer's disease (AD).",
        "source": "Abstract_30448613"
      }
    },
    "num_sources": 4
  },
  {
    "query": "What role do immune-related tissues and microglia play in AD genetics?",
    "answer": "Associated genes are strongly expressed in immune-related tissues and cell types (spleen, liver, and microglia). [30617256_sent_9] These results are a step forward in identifying the genetic factors that contribute to AD risk and add novel insights into the neurobiology of AD. [30617256_sent_3]",
    "citations": {
      "30617256_sent_6": {
        "text": "Associated genes are strongly expressed in immune-related tissues and cell types (spleen, liver, and microglia).",
        "source": "Abstract_30617256"
      },
      "30617256_sent_9": {
        "text": "These results are a step forward in identifying the genetic factors that contribute to AD risk and add novel insights into the neurobiology of AD.",
        "source": "Abstract_30617256"
      },
      "30617256_sent_3": {
        "text": "Here, we performed a large genome-wide association study of clinically diagnosed AD and AD-by-proxy (71,880 cases, 383,378 controls).",
        "source": "Abstract_30617256"
      }
    },
    "num_sources": 3
  },
  {
    "query": "How does age affect the genetic architecture of Alzheimer's disease?",
    "answer": "[30979435_sent_1] The risk of APOE for Alzheimer's disease (AD) is modified by age. [31055733_sent_1] Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the interplay of multiple genetic and non-genetic factors. [30448613_sent_1] The International Genomics of Alzheimer's Project (IGAP) is a consortium for characterizing the genetic architecture of Alzheimer's disease (AD).",
    "citations": {
      "30979435_sent_4": {
        "text": "Stratified gene-based genome-wide association studies and polygenic variation analyses were performed in the younger (60-79 years, N = 14,895) and older (>/=80 years, N = 6559) age-at-onset groups using Alzheimer's Disease Genetics Consortium data.",
        "source": "Abstract_30979435"
      },
      "30979435_sent_1": {
        "text": "The risk of APOE for Alzheimer's disease (AD) is modified by age.",
        "source": "Abstract_30979435"
      },
      "31055733_sent_1": {
        "text": "Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the interplay of multiple genetic and non-genetic factors.",
        "source": "Abstract_31055733"
      },
      "30448613_sent_1": {
        "text": "The International Genomics of Alzheimer's Project (IGAP) is a consortium for characterizing the genetic landscape of Alzheimer's disease (AD).",
        "source": "Abstract_30448613"
      }
    },
    "num_sources": 4
  },
  {
    "query": "What genes show differential effects between younger and older AD onset groups?",
    "answer": "30 genes demonstrated evidence of group-specific associations with AD at the false discovery rates (FDR)  0.05 in our gene-based and transcriptome-wide association analyses. [31055733_sent_5] The closest genes to 14 polymorphisms were not associated with AD at P  5E-06 in previous genome-wide association studies (GWAS).",
    "citations": {
      "30979435_sent_3": {
        "text": "We aim to investigate age-related genetic heterogeneity of AD and identify genomic loci with differential effects across age.",
        "source": "Abstract_30979435"
      },
      "30979435_sent_4": {
        "text": "Stratified gene-based genome-wide association studies and polygenic variation analyses were performed in the younger (60-79 years, N = 14,895) and older (>/=80 years, N = 6559) age-at-onset groups using Alzheimer's Disease Genetics Consortium data.",
        "source": "Abstract_30979435"
      },
      "31055733_sent_7": {
        "text": "In addition, 30 genes demonstrated evidence of group-specific associations with AD at the false discovery rates (FDR) < 0.05 in our gene-based and transcriptome-wide association analyses.",
        "source": "Abstract_31055733"
      },
      "31055733_sent_5": {
        "text": "The closest genes to 14 polymorphisms were not associated with AD at P < 5E-06 in previous genome-wide association studies (GWAS).",
        "source": "Abstract_31055733"
      }
    },
    "num_sources": 4
  },
  {
    "query": "How does hypertension influence the genetic risk of Alzheimer's disease?",
    "answer": "[31055733_sent_2] Hypertension is one of the AD risk factors that has been linked to underlying pathological changes like senile plaques and neurofibrillary tangles formation as well as hippocampal atrophy. [30979435_sent_1] The risk of APOE for Alzheimer's disease (AD) is modified by age.",
    "citations": {
      "31055733_sent_1": {
        "text": "Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the interplay of multiple genetic and non-genetic factors.",
        "source": "Abstract_31055733"
      },
      "30413934_sent_1": {
        "text": "Cardiovascular (CV)- and lifestyle-associated risk factors (RFs) are increasingly recognized as important for Alzheimer's disease (AD) pathogenesis.",
        "source": "Abstract_30413934"
      },
      "31055733_sent_2": {
        "text": "Hypertension is one of the AD risk factors that has been linked to underlying pathological changes like senile plaques and neurofibrillary tangles formation as well as hippocampal atrophy.",
        "source": "Abstract_31055733"
      },
      "30979435_sent_1": {
        "text": "The risk of APOE for Alzheimer's disease (AD) is modified by age.",
        "source": "Abstract_30979435"
      }
    },
    "num_sources": 4
  },
  {
    "query": "What is the function of expression quantitative trait loci (eQTL) in AD-associated genes?",
    "answer": "[30448613_sent_7] The IGAP SNPs in ABCA7, CD2AP, and CD33 each acted as eQTL for AD-associated genes in brain. [30448613_sent_8] Our approach for identifying proxies and examining eQTL highlighted potentially impactful, novel gene regulatory phenomena pertinent to the AD phenotype. [30979435_sent_3] We aim to investigate age-related genetic heterogeneity of AD and identify genomic loci with differential effects across age.",
    "citations": {
      "30448613_sent_7": {
        "text": "The IGAP SNPs in ABCA7, CD2AP, and CD33 each acted as eQTL for AD-associated genes in brain.",
        "source": "Abstract_30448613"
      },
      "30448613_sent_8": {
        "text": "Our approach for identifying proxies and examining eQTL highlighted potentially impactful, novel gene regulatory phenomena pertinent to the AD phenotype.",
        "source": "Abstract_30448613"
      },
      "30979435_sent_3": {
        "text": "We aim to investigate age-related genetic heterogeneity of AD and identify genomic loci with differential effects across age.",
        "source": "Abstract_30979435"
      }
    },
    "num_sources": 3
  },
  {
    "query": "Which chromosomal regions contain novel AD risk loci identified in recent GWAS?",
    "answer": "[31055733_sent_8] The chromosomal regions corresponding to four genes (i.e., 2p13.1, 9p13.3, 17q12, and 18q21.1) were not associated with AD at P  5E-06 in previous GWAS. [31055733_sent_4] Our genome-wide association analyses revealed significant associations of 15 novel potentially AD-associated polymorphisms (P  5E-06) that were located outside the chromosome 19q13 region and were significant either in hypertensive or non-hypertensive groups. [31055733_sent_6] Also, four of them were located within two chromosomal regions (i.e., 3q13.11 and 17q21.2) that were not associated with AD at P  5E-06 before. [30448613_sent_2] The identified and/or confirmed 19 single-nucleotide polymorphisms (SNPs) associated with AD are located on non-coding DNA regions, and their functional impacts on AD are as yet poorly understood.",
    "citations": {
      "31055733_sent_8": {
        "text": "The chromosomal regions corresponding to four genes (i.e., 2p13.1, 9p13.3, 17q12, and 18q21.1) were not associated with AD at P < 5E-06 in previous GWAS.",
        "source": "Abstract_31055733"
      },
      "31055733_sent_4": {
        "text": "Our genome-wide association analyses revealed significant associations of 15 novel potentially AD-associated polymorphisms (P < 5E-06) that were located outside the chromosome 19q13 region and were significant either in hypertensive or non-hypertensive groups.",
        "source": "Abstract_31055733"
      },
      "31055733_sent_6": {
        "text": "Also, four of them were located within two chromosomal regions (i.e., 3q13.11 and 17q21.2) that were not associated with AD at P < 5E-06 before.",
        "source": "Abstract_31055733"
      },
      "30448613_sent_2": {
        "text": "The identified and/or confirmed 19 single-nucleotide polymorphisms (SNPs) associated with AD are located on non-coding DNA regions, and their functional impacts on AD are as yet poorly understood.",
        "source": "Abstract_30448613"
      }
    },
    "num_sources": 4
  },
  {
    "query": "How does plasma lipid profile contribute to AD genetic risk beyond APOE?",
    "answer": "[30413934_sent_4] In fold enrichment plots, we observed robust genetic enrichment in AD as a function of plasma lipids (TG, TC, LDL, and HDL); we found minimal AD genetic enrichment conditional on BMI, T2D, CAD, and WHR. [30413934_sent_5] Beyond APOE, at conjunction FDR  0.05 we identified 90 SNPs on 19 different chromosomes that were jointly associated with AD and CV-associated outcomes.",
    "citations": {
      "30413934_sent_2": {
        "text": "Beyond the epsilon4 allele of apolipoprotein E (APOE), comparatively little is known about whether CV-associated genes also increase risk for AD.",
        "source": "Abstract_30413934"
      },
      "30413934_sent_9": {
        "text": "Beyond APOE, we show that the polygenic component of AD is enriched for lipid-associated RFs.",
        "source": "Abstract_30413934"
      },
      "30413934_sent_4": {
        "text": "In fold enrichment plots, we observed robust genetic enrichment in AD as a function of plasma lipids (TG, TC, LDL, and HDL); we found minimal AD genetic enrichment conditional on BMI, T2D, CAD, and WHR.",
        "source": "Abstract_30413934"
      },
      "30413934_sent_5": {
        "text": "Beyond APOE, at conjunction FDR < 0.05 we identified 90 SNPs on 19 different chromosomes that were jointly associated with AD and CV-associated outcomes.",
        "source": "Abstract_30413934"
      }
    },
    "num_sources": 4
  },
  {
    "query": "What is AD-by-proxy and how does it correlate with clinically diagnosed Alzheimer's disease?",
    "answer": "[30617256_sent_4] AD-by-proxy, based on parental diagnoses, showed strong genetic correlation with AD (rg = 0.81). [30617256_sent_3] Here, we performed a large genome-wide association study of clinically diagnosed AD and AD-by-proxy (71,880 cases, 383,378 controls). [31055733_sent_1] Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the interplay of multiple genetic and non-genetic factors. [30617256_sent_1] Alzheimer's disease (AD) is highly heritable and recent studies have identified over 20 disease-associated genomic loci.",
    "citations": {
      "30617256_sent_4": {
        "text": "AD-by-proxy, based on parental diagnoses, showed strong genetic correlation with AD (rg = 0.81).",
        "source": "Abstract_30617256"
      },
      "30617256_sent_3": {
        "text": "Here, we performed a large genome-wide association study of clinically diagnosed AD and AD-by-proxy (71,880 cases, 383,378 controls).",
        "source": "Abstract_30617256"
      },
      "31055733_sent_1": {
        "text": "Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the interplay of multiple genetic and non-genetic factors.",
        "source": "Abstract_31055733"
      },
      "30617256_sent_1": {
        "text": "Alzheimer's disease (AD) is highly heritable and recent studies have identified over 20 disease-associated genomic loci.",
        "source": "Abstract_30617256"
      }
    },
    "num_sources": 4
  },
  {
    "query": "What are the specific genes like BIN1, PICALM, and MS4A4E associated with AD?",
    "answer": "[30979435_sent_7] APOE region, BIN1, OR2S2, MS4A4E, and PICALM were identified at the gene-based genome-wide significance (p  2.73 x 10(-6)) with larger effects at younger age (except MS4A4E). [30617256_sent_9] These results are a step forward in identifying the genetic factors that contribute to AD risk and add novel insights into the neurobiology of AD.",
    "citations": {
      "30979435_sent_7": {
        "text": "APOE region, BIN1, OR2S2, MS4A4E, and PICALM were identified at the gene-based genome-wide significance (p < 2.73 x 10(-6)) with larger effects at younger age (except MS4A4E).",
        "source": "Abstract_30979435"
      },
      "30617256_sent_9": {
        "text": "These results are a step forward in identifying the genetic factors that contribute to AD risk and add novel insights into the neurobiology of AD.",
        "source": "Abstract_30617256"
      }
    },
    "num_sources": 2
  },
  {
    "query": "How do genes like ABCA7, CD2AP, and CD33 act as eQTL in brain tissue?",
    "answer": "The IGAP SNPs in ABCA7, CD2AP, and CD33 each acted as eQTL for AD-associated genes in brain",
    "citations": {
      "30448613_sent_7": {
        "text": "The IGAP SNPs in ABCA7, CD2AP, and CD33 each acted as eQTL for AD-associated genes in brain.",
        "source": "Abstract_30448613"
      },
      "30617256_sent_6": {
        "text": "Associated genes are strongly expressed in immune-related tissues and cell types (spleen, liver, and microglia).",
        "source": "Abstract_30617256"
      }
    },
    "num_sources": 2
  },
  {
    "query": "What biological pathways are enriched in Alzheimer's disease genetics?",
    "answer": "[30617256_sent_1]",
    "citations": {
      "31055733_sent_1": {
        "text": "Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the interplay of multiple genetic and non-genetic factors.",
        "source": "Abstract_31055733"
      },
      "30448613_sent_1": {
        "text": "The International Genomics of Alzheimer's Project (IGAP) is a consortium for characterizing the genetic landscape of Alzheimer's disease (AD).",
        "source": "Abstract_30448613"
      },
      "30617256_sent_1": {
        "text": "Alzheimer's disease (AD) is highly heritable and recent studies have identified over 20 disease-associated genomic loci.",
        "source": "Abstract_30617256"
      }
    },
    "num_sources": 3
  }
]